Myers Scott Dunseth
- SEC CIK
- 0001356256
No open-market purchases or sales filed in the past year.
Current role at each company
- ZNTL Zentalis Pharmaceuticals, Inc.Directoras of Jun 18, 2026
- DVAX Dynavax Technologies CorpDirectoras of Feb 10, 2026
- HARP Harpoon Therapeutics, Inc.Directoras of Mar 11, 2024
- RNAC Cartesian Therapeutics, Inc.Directoras of Nov 15, 2023
- VRDN Viridian Therapeutics, Inc.Chief Executive Officeras of Apr 12, 2023
Show 1 more company
- Trillium Therapeutics Inc.Directoras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Myers Scott Dunseth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DVAX Dynavax Technologies Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Myers Scott DunsethDirector | PPurchase | +3.80K | $10.82 | +$41.1K | +12.2%35.0K after |
ZNTL Zentalis Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 (view filing) | Apr 30 | Same day | Myers Scott DunsethDirector | PPurchase | +21.0K | $1.40 | +$29.4K | +8.1%281.2K after |
VRDN Viridian Therapeutics, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 (view filing) | Apr 12 | Same day | Myers Scott DunsethChief Executive Officer | PPurchase | +4.00K | $25.37 | +$101.5K | +1.6%259.5K after | |
| Mar 13, 2023 (view filing) | Mar 13 | Same day | Myers Scott DunsethChief Executive Officer | PPurchase | +5.50K | $29.15 | +$160.3K | +2.2%255.5K after |